Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Early-life stress alters affective behaviors in adult mice through persistent activation of CRH-BDNF signaling in the oval bed nucleus of the stria terminalis

Open access

Abstract

Early-life stress (ELS) leads to stress-related psychopathology in adulthood. Although dysfunction of corticotropin-releasing hormone (CRH) signaling in the bed nucleus of the stria terminalis (BNST) mediates chronic stress-induced maladaptive affective behaviors that are historically associated with mood disorders such as anxiety and depression, it remains unknown whether ELS affects CRH function in the adult BNST. Here we applied a well-established ELS paradigm (24 h maternal separation (MS) at postnatal day 3) and assessed the effects on CRH signaling and electrophysiology in the oval nucleus of BNST (ovBNST) of adult male mouse offspring. ELS increased maladaptive affective behaviors, and amplified mEPSCs and decreased M-currents (a voltage-gated K+ current critical for stabilizing membrane potential) in ovBNST CRH neurons, suggesting enhanced cellular excitability. Furthermore, ELS increased the numbers of CRH+ and PACAP+ (the pituitary adenylate cyclase-activating polypeptide, an upstream CRH regulator) cells and decreased STEP+ (striatal-enriched protein tyrosine phosphatase, a CRH inhibitor) cells in BNST. Interestingly, ELS also increased BNST brain-derived neurotrophic factor (BDNF) expression, indicating enhanced neuronal plasticity. These electrophysiological and behavioral effects of ELS were reversed by chronic application of the CRHR1-selective antagonist R121919 into ovBNST, but not when BDNF was co-administered. In addition, the neurophysiological effects of BDNF on M-currents and mEPSCs in BNST CRH neurons mimic effects and were abolished by PKC antagonism. Together, our findings indicate that ELS results in a long-lasting activation of CRH signaling in the mouse ovBNST. These data highlight a regulatory role of CRHR1 in the BNST and for BDNF signaling in mediating ELS-induced long-term behavioral changes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-020-01070-3

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Experimental scheme depicting the early-life stress (ELS) paradigm and a comparison of the negative-valence behavioral outcomes of maternally separated (MS) mice in adulthood. a Newborn mice at postnatal day 3 (PND3) were subjected to a severe early-life stress (ELS), consisting of 24 h of maternal separation (MS) from their mother. When they reached adulthood at 10 to 12 weeks of age, they were separated into different cohorts for different experimental tests. For the first cohort, a series of negative-valence behaviors was assessed, including the sucrose preference test (SPT), elevated plus maze (EPM) test, open-field (OF) test, novelty suppressed feeding (NSF) test, and forced swimming test (FST). Mice were then perfused for immunohistochemical (IHC) studies. The second cohort was used for electrophysiological (Ephys) recordings (including M-current and miniature excitatory postsynaptic currents) of CRH neurons of the oval nucleus of the bed nucleus of the stria terminalis (ovBNST). For the third cohort, brains were collected and BNST tissue was extracted for a quantitative PCR (qPCR) study. Blood samples were collected to assess corticosterone (CORT) concentrations. b Body weight gain from postnatal day (PND) 3–10 was significantly decreased in the maternal separation (MS) group (n = 7) compared to the control (Control) group (n = 7). c Basal plasma corticosterone (CORT) concentration was significantly increased in the maternal separation (MS) group (n = 8) compared to the Control group (n = 9). d The sucrose preference percentage was significantly decreased in the MS group (n = 8) compared to Controls (n = 10). e Frequency in the open arm was significantly decreased (p < 0.001) in MS (n = 10) vs. Controls (n = 10) mice in the EPM test. f Duration in the open arm was significantly decreased (p < 0.01) in MS (n = 10) vs. Control (n = 10) mice in the elevated plus maze (EPM) test. g Comparison of the distance that MS (n = 9) mice vs. Control (n = 10) mice traveled in the center of open-field (OF) test revealed a significant decrease for the MS group (p < 0.05). h The frequency at which the mice enter into the center of the open-field (OF) was significantly decreased (p < 0.05) in MS (n = 9) compared to Control (n = 10) mice. i Duration of the time spend in the center of the open-field (OF) was significantly decreased (p < 0.01) in MS (n = 9) vs. Control (n = 10) mice. j The latency to eat food pellets in the novelty suppressed feeding (NSF) test was significantly increased (p < 0.05) in the MS (n = 9) mice compared with Control (n = 10) mice (n = 9–10 animals per group; *p < 0.05; **p < 0.01; ***p < 0.001; NS: no significant difference).
Fig. 1 Experimental scheme depicting the early-life stress (ELS) paradigm and a comparison of the negative-valence behavioral outcomes of maternally separated (MS) mice in adulthood. a Newborn mice at postnatal day 3 (PND3) were subjected to a severe early-life stress (ELS), consisting of 24 h of maternal separation (MS) from their mother. When they reached adulthood at 10 to 12 weeks of age, they were separated into different cohorts for different experimental tests. For the first cohort, a series of negative-valence behaviors was assessed, including the sucrose preference test (SPT), elevated plus maze (EPM) test, open-field (OF) test, novelty suppressed feeding (NSF) test, and forced swimming test (FST). Mice were then perfused for immunohistochemical (IHC) studies. The second cohort was used for electrophysiological (Ephys) recordings (including M-current and miniature excitatory postsynaptic currents) of CRH neurons of the oval nucleus of the bed nucleus of the stria terminalis (ovBNST). For the third cohort, brains were collected and BNST tissue was extracted for a quantitative PCR (qPCR) study. Blood samples were collected to assess corticosterone (CORT) concentrations. b Body weight gain from postnatal day (PND) 3–10 was significantly decreased in the maternal separation (MS) group (n = 7) compared to the control (Control) group (n = 7). c Basal plasma corticosterone (CORT) concentration was significantly increased in the maternal separation (MS) group (n = 8) compared to the Control group (n = 9). d The sucrose preference percentage was significantly decreased in the MS group (n = 8) compared to Controls (n = 10). e Frequency in the open arm was significantly decreased (p < 0.001) in MS (n = 10) vs. Controls (n = 10) mice in the EPM test. f Duration in the open arm was significantly decreased (p < 0.01) in MS (n = 10) vs. Control (n = 10) mice in the elevated plus maze (EPM) test. g Comparison of the distance that MS (n = 9) mice vs. Control (n = 10) mice traveled in the center of open-field (OF) test revealed a significant decrease for the MS group (p < 0.05). h The frequency at which the mice enter into the center of the open-field (OF) was significantly decreased (p < 0.05) in MS (n = 9) compared to Control (n = 10) mice. i Duration of the time spend in the center of the open-field (OF) was significantly decreased (p < 0.01) in MS (n = 9) vs. Control (n = 10) mice. j The latency to eat food pellets in the novelty suppressed feeding (NSF) test was significantly increased (p < 0.05) in the MS (n = 9) mice compared with Control (n = 10) mice (n = 9–10 animals per group; *p < 0.05; **p < 0.01; ***p < 0.001; NS: no significant difference).CC BY · PubMed Central
Fig. 2 Comparison of CRH, PACAP, and STEP-immunostaining and qPCR comparison of mRNA expression levels of CRH, PACAP, STEP, CRHR1, and CRHR2 in BNST from Control vs. maternally separated (MS) mice. a Example of CRH+ cells in BNST; white arrows point to typical CRH+ cells; scale bar 50 μm. b Example of PACAP+ cells in BNST; white arrows point to typical PACAP+ cells; scale bar 50 μm. c Example of STEP+ cells in BNST; white arrows point to typical STEP+ cells; scale bar 50 μm. d Comparison of CRH+ cell numbers in ovBNST showed higher number of CRH+ cells from MS (n = 6) compared to Control mice (n = 6). e Similarly, a comparison of PACAP+ cell number in ovBNST showed higher number of PACAP+ cells from MS mice (n = 6) compared to Control mice (n = 6). f On the contrary, comparison of STEP+ cell numbers in ovBNST revealed lower numbers of STEP+ cells from MS mice (n = 6) compared to Control mice (n = 6). g mRNA expression of CRH was significantly increased in BNST from the MS (n = 8) relative to the Control mice (n = 8; p < 0.05). h Similarly, PACAP mRNA expression was higher in the BNST from the MS (n = 8) vs. the Control group (n = 7) (p < 0.05). i On the contrary, comparison of STEP mRNA in the BNST revealed lower STEP mRNA levels in the MS (n = 8) vs. the Control group (n = 8) (p < 0.05). j CRHR1 mRNA expression was higher in the BNST of the MS (n = 8) group compared to the Control (n = 9) group of mice (p < 0.05). k No significant difference was found for mRNA expression of CRHR2 in the BNST from Control (n = 8) vs. MS (n = 8) mice (p > 0.05) (*p < 0.05; **p < 0.01; ***p < 0.001. NS: nonsignificant different (p > 0.05)).
Fig. 2 Comparison of CRH, PACAP, and STEP-immunostaining and qPCR comparison of mRNA expression levels of CRH, PACAP, STEP, CRHR1, and CRHR2 in BNST from Control vs. maternally separated (MS) mice. a Example of CRH+ cells in BNST; white arrows point to typical CRH+ cells; scale bar 50 μm. b Example of PACAP+ cells in BNST; white arrows point to typical PACAP+ cells; scale bar 50 μm. c Example of STEP+ cells in BNST; white arrows point to typical STEP+ cells; scale bar 50 μm. d Comparison of CRH+ cell numbers in ovBNST showed higher number of CRH+ cells from MS (n = 6) compared to Control mice (n = 6). e Similarly, a comparison of PACAP+ cell number in ovBNST showed higher number of PACAP+ cells from MS mice (n = 6) compared to Control mice (n = 6). f On the contrary, comparison of STEP+ cell numbers in ovBNST revealed lower numbers of STEP+ cells from MS mice (n = 6) compared to Control mice (n = 6). g mRNA expression of CRH was significantly increased in BNST from the MS (n = 8) relative to the Control mice (n = 8; p < 0.05). h Similarly, PACAP mRNA expression was higher in the BNST from the MS (n = 8) vs. the Control group (n = 7) (p < 0.05). i On the contrary, comparison of STEP mRNA in the BNST revealed lower STEP mRNA levels in the MS (n = 8) vs. the Control group (n = 8) (p < 0.05). j CRHR1 mRNA expression was higher in the BNST of the MS (n = 8) group compared to the Control (n = 9) group of mice (p < 0.05). k No significant difference was found for mRNA expression of CRHR2 in the BNST from Control (n = 8) vs. MS (n = 8) mice (p > 0.05) (*p < 0.05; **p < 0.01; ***p < 0.001. NS: nonsignificant different (p > 0.05)).CC BY · PubMed Central
Fig. 3 Maternal separation (MS) increased cellular excitability of CRH neurons in the oval nucleus of the bed nucleus of the stria terminalis (ovBNST) of adult mice by inhibiting M-current and potentiating miniature excitatory postsynaptic current (mEPSC). a Typical example of c-fos immunopositive cells in BNST; scale bar 50 μm. b c-fos immunopositive cell number was significantly increased in the total anterior BNST in MS (n = 6) vs. Control (n = 6) mice. c c-fos cell number was significantly increased in the oval nucleus of BNST (ovBNST) in MS (n = 6) vs. Control (n = 6) mice. d c-fos immunostaining pattern in BNST from Control mice. e c-fos immunostaining pattern in BNST from maternally separated (MS) mice. f CRH immunostaining (red; pointed by star) in the ovBNST from Control mice. g c-fos immunostaining (green; pointed by white arrow) in the ovBNST of Control mice. h Lack of colocalization pattern of c-fos/CRH in the ovBNST of Control mice. i CRH immunostaining in the ovBNST from MS mice (red; pointed by white arrow). j c-fos immunostaining in the ovBNST of MS mice (green; pointed by white arrow). k Colocalization pattern of c-fos/CRH in the ovBNST of MS mice (yellow; pointed by white arrow). scale bar: 50 μm. l Quantification of average percentage of number of c-fos/CRH colocalized cells in the total number of CRH-immunopositive cells in the ovBNST shows a higher percentage in the MS group of mice (n = 5) compared to Control mice (n = 5). m Example showing the anatomical location of the electrophysiological recording site in the ovBNST (whole-cell patch clamping); ic: internal capsule; ac: anterior commissure. Mice were subjected to a 24 h MS protocol at PND3, after which BNST coronal slices were used for electrophysiological recording at adulthood. n A representative example of a CRH+ cell in the mice ovBNST after patch clamp recording. Confirmation of the CRH neurochemical profile was achieved by intracellular dye labeling (Alexa Fluor 633, green) followed by immunohistochemical analysis (Alexa Fluor 594, red). White arrow points to a confirmed recorded CRH+ neuron (in yellow color) in ovBNST. LV: lateral ventricular. Scale bar 50 μm. o Examples of recorded mEPSC traces of ovBNST CRH neurons from Control vs. MS mice. Example trace shows 50 pA and 1 s. p Average mEPSC amplitude recorded in the CRH neurons from ovBNST is increased in MS (n = 8 cells) compared to Control mice (n = 8 cells). q For the average mEPSC frequency recorded in CRH neurons from ovBNST, there is no significant difference between MS (n = 8 cells) and Control cells (n = 8 cells). r Comparison of cellular resting membrane potential (RMP) in CRH neurons in ovBNST from Control (n = 8 cells) vs. MS mice (n = 7 cells) revealed a depolarized RMP in the MS mice. s Comparison of cellular input resistance (IR) in ovBNST CRH neurons between Control mice (n = 8 cells) vs. MS mice (n = 7 cells) revealed a higher IR in the MS mice. t The deactivation protocol used to record the M-current. From a holding potential of −60 mV, a voltage jump to −20 mV (300 ms) is followed by steps from −30 to −75 mV in 5 mV increments (500 ms). u Examples of the I–V curve of the M-current allow comparison of recordings at 0, 10, and 20 min, and shows the M-current does not run down during 20 min recording (n = 7 cells). v An example of a continuous action potential firing activity trace recorded under current-clamp mode in an ovBNST CRH neuron during bath perfusion with the selective KCNQ/Kv7 channel blocker XE991 (40 μM). Robust firing bursts were found after around 5 min XE991 application. w Example of M-current traces shown at 0, 10, and 20 min, and after subsequent perfusion with KCNQ-selective channel blocker XE991 (bath incubation, 40 μM). M-currents were robustly suppressed after XE991 application. x I–V plot shows diminished outward M-current in ovBNST CRH neurons in the MS mice ranging from −75 to −25 mV compared to Control mice (each n = 8 cells). A significant difference was found in the voltage range between −45 and −25 mV. y Example for comparison purposes of a western blotting showing protein bands of pSer845-GluR1 (MW = 102 kDa) in BNST tissue of Control mice (lane 1–4; C1–C4) vs. MS mice (lane 5–8; M1–M4). Total GluR1 (MW = 100 kDa) was used as the internal control. GAPDH (MW = 37 kDa) was also shown. z Representative graph showing an increase in relative percentage of expression level of p-GluR1 (Ser845) in BNST tissue from CVMS (n = 5 mice) vs. Control (n = 5 mice) mice (p < 0.01) normalized with total GluR1 expression. (*p < 0.05; **p < 0.01; ***p < 0.001; NS nonsignificant different (p > 0.05).
Fig. 3 Maternal separation (MS) increased cellular excitability of CRH neurons in the oval nucleus of the bed nucleus of the stria terminalis (ovBNST) of adult mice by inhibiting M-current and potentiating miniature excitatory postsynaptic current (mEPSC). a Typical example of c-fos immunopositive cells in BNST; scale bar 50 μm. b c-fos immunopositive cell number was significantly increased in the total anterior BNST in MS (n = 6) vs. Control (n = 6) mice. c c-fos cell number was significantly increased in the oval nucleus of BNST (ovBNST) in MS (n = 6) vs. Control (n = 6) mice. d c-fos immunostaining pattern in BNST from Control mice. e c-fos immunostaining pattern in BNST from maternally separated (MS) mice. f CRH immunostaining (red; pointed by star) in the ovBNST from Control mice. g c-fos immunostaining (green; pointed by white arrow) in the ovBNST of Control mice. h Lack of colocalization pattern of c-fos/CRH in the ovBNST of Control mice. i CRH immunostaining in the ovBNST from MS mice (red; pointed by white arrow). j c-fos immunostaining in the ovBNST of MS mice (green; pointed by white arrow). k Colocalization pattern of c-fos/CRH in the ovBNST of MS mice (yellow; pointed by white arrow). scale bar: 50 μm. l Quantification of average percentage of number of c-fos/CRH colocalized cells in the total number of CRH-immunopositive cells in the ovBNST shows a higher percentage in the MS group of mice (n = 5) compared to Control mice (n = 5). m Example showing the anatomical location of the electrophysiological recording site in the ovBNST (whole-cell patch clamping); ic: internal capsule; ac: anterior commissure. Mice were subjected to a 24 h MS protocol at PND3, after which BNST coronal slices were used for electrophysiological recording at adulthood. n A representative example of a CRH+ cell in the mice ovBNST after patch clamp recording. Confirmation of the CRH neurochemical profile was achieved by intracellular dye labeling (Alexa Fluor 633, green) followed by immunohistochemical analysis (Alexa Fluor 594, red). White arrow points to a confirmed recorded CRH+ neuron (in yellow color) in ovBNST. LV: lateral ventricular. Scale bar 50 μm. o Examples of recorded mEPSC traces of ovBNST CRH neurons from Control vs. MS mice. Example trace shows 50 pA and 1 s. p Average mEPSC amplitude recorded in the CRH neurons from ovBNST is increased in MS (n = 8 cells) compared to Control mice (n = 8 cells). q For the average mEPSC frequency recorded in CRH neurons from ovBNST, there is no significant difference between MS (n = 8 cells) and Control cells (n = 8 cells). r Comparison of cellular resting membrane potential (RMP) in CRH neurons in ovBNST from Control (n = 8 cells) vs. MS mice (n = 7 cells) revealed a depolarized RMP in the MS mice. s Comparison of cellular input resistance (IR) in ovBNST CRH neurons between Control mice (n = 8 cells) vs. MS mice (n = 7 cells) revealed a higher IR in the MS mice. t The deactivation protocol used to record the M-current. From a holding potential of −60 mV, a voltage jump to −20 mV (300 ms) is followed by steps from −30 to −75 mV in 5 mV increments (500 ms). u Examples of the I–V curve of the M-current allow comparison of recordings at 0, 10, and 20 min, and shows the M-current does not run down during 20 min recording (n = 7 cells). v An example of a continuous action potential firing activity trace recorded under current-clamp mode in an ovBNST CRH neuron during bath perfusion with the selective KCNQ/Kv7 channel blocker XE991 (40 μM). Robust firing bursts were found after around 5 min XE991 application. w Example of M-current traces shown at 0, 10, and 20 min, and after subsequent perfusion with KCNQ-selective channel blocker XE991 (bath incubation, 40 μM). M-currents were robustly suppressed after XE991 application. x I–V plot shows diminished outward M-current in ovBNST CRH neurons in the MS mice ranging from −75 to −25 mV compared to Control mice (each n = 8 cells). A significant difference was found in the voltage range between −45 and −25 mV. y Example for comparison purposes of a western blotting showing protein bands of pSer845-GluR1 (MW = 102 kDa) in BNST tissue of Control mice (lane 1–4; C1–C4) vs. MS mice (lane 5–8; M1–M4). Total GluR1 (MW = 100 kDa) was used as the internal control. GAPDH (MW = 37 kDa) was also shown. z Representative graph showing an increase in relative percentage of expression level of p-GluR1 (Ser845) in BNST tissue from CVMS (n = 5 mice) vs. Control (n = 5 mice) mice (p < 0.01) normalized with total GluR1 expression. (*p < 0.05; **p < 0.01; ***p < 0.001; NS nonsignificant different (p > 0.05).CC BY · PubMed Central
Fig. 4 CRHR1-selective antagonist R121919 infused into ovBNST reverses the maladaptive electrophysiological and affective behavioral effects of maternal separation (MS). These were abolished by co-incubation with forskolin. An increased expression level of BDNF was found in BNST from maternally separated (MS) mice, which was normalized by local in vivo application of the CRHR1-selective antagonist R121919 into ovBNST. a Scheme showing that the CRHR1-selective antagonist R121919 (1 μg dissolved in 0.5 μl saline) was chronically and bilaterally infused into ovBNST of adult MS mice through a cannula for a continuous period of 7 days to compare its effects on maladaptive affective behaviors in the EPM test, OF test, SPT test and NSF test. b Anatomical example shows the location of the cannulas that were bilaterally inserted into ovBNST. c The sucrose preference percentage was significantly increased in MS + R121919 mice (n = 7) compared to MS + Saline mice (n = 10). d Duration; time spent in the open arm in the EPM was not significantly changed in MS + R121919 (n = 7) compared to MS + Saline mice (n = 10). e The frequency of open arm entries in the EPM test was significantly increased in MS + R121919 (n = 7) compared to MS + Saline mice (n = 10). f Duration of time spend in the center of the OF was not significantly different in MS + R121919 (n = 7) relative to MS + Saline mice (n = 10). g Distance traveled in the center of OF was significantly increased in MS + R121919 mice (n = 7) compared to MS + Saline mice (n = 10). h Frequency of center entries in the OF was significantly increased in MS + R121919 mice (n = 7) compared to MS + Saline mice (n = 10). i The latency to pellet consumption in the NSF was significantly decreased in MS + R121919 mice (n = 7) compared to MS + Saline mice (n = 10). j Pre-incubation of BNST brain slices from MS mice with 10 μM CRHR1-selective antagonist R121919 (n = 7 cells) for 60 min significantly normalized the decreased outward M-current in CRH neurons from MS mice incubated with Vehicle (n = 8 cells) compared to Control mice (n = 8 cells). R121919 had no effect on Control slices (n = 8 cells each condition). k The mEPSC amplitude was significantly decreased in R121919 pre-incubated cells (n = 7 cells) compared to Vehicle-treated cells from MS mice (n = 8 cells). R121919 has no effect on Control slices (n = 8 cells each condition). l mEPSC frequency has no significant change in R121919 pre-incubated cells (n = 7 cells) compared to untreated cells from MS mice (n = 8 cells). R121919 also has no effect on Control slices (n = 8 cells each condition). m R121919’s reversal effect on the M-current was abolished by co-incubation with forskolin in BNST slices from MS mice with Vehicle treated (n = 8 or 7 cells each condition). n R121919’s reversal effect on the mEPSC amplitude was abolished by co-incubation with forskolin in BNST slices from MS mice with Vehicle treated (n = 8 cells each condition). o R121919 had no effect on the mEPSC frequency when co-incubated with forskolin in BNST slices from MS mice with Vehicle treated (n = 8 or 7 cells each condition). p Example of a western blotting showing protein bands representing BDNF (MW = 17 kDa) in BNST tissue of MS (lane 1–5; M1–M5) vs. Control mice (lane 6–10; C1–C5). GAPDH (MW = 37 kDa) was used as the internal control. q Representative graph showing an increased relative percentage of BDNF expression in BNST tissue from MS (n = 6 mice) vs. Control (n = 5 mice; p < 0.01) mice. r Example of western blotting showing protein bands of BDNF (MW = 17 kDa) in BNST tissue from MS mice with chronic R121919 infusion into their ovBNST for a continuous 7 days (lane 6–9; R1–R4) vs. MS mice (lane 1–5; M1–M5). GAPDH (MW = 37 kDa) was used as the internal control. s Representative graph showing an increased relative percentage of BDNF expression in BNST tissue from MS + R121919 (n = 6 mice) compared with MS + Saline (n = 5 mice; p < 0.01) mice. *p < 0.05; **p < 0.01; ***p < 0.001; NS not significantly different).
Fig. 4 CRHR1-selective antagonist R121919 infused into ovBNST reverses the maladaptive electrophysiological and affective behavioral effects of maternal separation (MS). These were abolished by co-incubation with forskolin. An increased expression level of BDNF was found in BNST from maternally separated (MS) mice, which was normalized by local in vivo application of the CRHR1-selective antagonist R121919 into ovBNST. a Scheme showing that the CRHR1-selective antagonist R121919 (1 μg dissolved in 0.5 μl saline) was chronically and bilaterally infused into ovBNST of adult MS mice through a cannula for a continuous period of 7 days to compare its effects on maladaptive affective behaviors in the EPM test, OF test, SPT test and NSF test. b Anatomical example shows the location of the cannulas that were bilaterally inserted into ovBNST. c The sucrose preference percentage was significantly increased in MS + R121919 mice (n = 7) compared to MS + Saline mice (n = 10). d Duration; time spent in the open arm in the EPM was not significantly changed in MS + R121919 (n = 7) compared to MS + Saline mice (n = 10). e The frequency of open arm entries in the EPM test was significantly increased in MS + R121919 (n = 7) compared to MS + Saline mice (n = 10). f Duration of time spend in the center of the OF was not significantly different in MS + R121919 (n = 7) relative to MS + Saline mice (n = 10). g Distance traveled in the center of OF was significantly increased in MS + R121919 mice (n = 7) compared to MS + Saline mice (n = 10). h Frequency of center entries in the OF was significantly increased in MS + R121919 mice (n = 7) compared to MS + Saline mice (n = 10). i The latency to pellet consumption in the NSF was significantly decreased in MS + R121919 mice (n = 7) compared to MS + Saline mice (n = 10). j Pre-incubation of BNST brain slices from MS mice with 10 μM CRHR1-selective antagonist R121919 (n = 7 cells) for 60 min significantly normalized the decreased outward M-current in CRH neurons from MS mice incubated with Vehicle (n = 8 cells) compared to Control mice (n = 8 cells). R121919 had no effect on Control slices (n = 8 cells each condition). k The mEPSC amplitude was significantly decreased in R121919 pre-incubated cells (n = 7 cells) compared to Vehicle-treated cells from MS mice (n = 8 cells). R121919 has no effect on Control slices (n = 8 cells each condition). l mEPSC frequency has no significant change in R121919 pre-incubated cells (n = 7 cells) compared to untreated cells from MS mice (n = 8 cells). R121919 also has no effect on Control slices (n = 8 cells each condition). m R121919’s reversal effect on the M-current was abolished by co-incubation with forskolin in BNST slices from MS mice with Vehicle treated (n = 8 or 7 cells each condition). n R121919’s reversal effect on the mEPSC amplitude was abolished by co-incubation with forskolin in BNST slices from MS mice with Vehicle treated (n = 8 cells each condition). o R121919 had no effect on the mEPSC frequency when co-incubated with forskolin in BNST slices from MS mice with Vehicle treated (n = 8 or 7 cells each condition). p Example of a western blotting showing protein bands representing BDNF (MW = 17 kDa) in BNST tissue of MS (lane 1–5; M1–M5) vs. Control mice (lane 6–10; C1–C5). GAPDH (MW = 37 kDa) was used as the internal control. q Representative graph showing an increased relative percentage of BDNF expression in BNST tissue from MS (n = 6 mice) vs. Control (n = 5 mice; p < 0.01) mice. r Example of western blotting showing protein bands of BDNF (MW = 17 kDa) in BNST tissue from MS mice with chronic R121919 infusion into their ovBNST for a continuous 7 days (lane 6–9; R1–R4) vs. MS mice (lane 1–5; M1–M5). GAPDH (MW = 37 kDa) was used as the internal control. s Representative graph showing an increased relative percentage of BDNF expression in BNST tissue from MS + R121919 (n = 6 mice) compared with MS + Saline (n = 5 mice; p < 0.01) mice. *p < 0.05; **p < 0.01; ***p < 0.001; NS not significantly different).CC BY · PubMed Central
Fig. 5 MS effects on maladaptive behaviors and BNST neurophysiological parameters persist in the presence of BDNF even when CRHR1 is blocked. Maladaptive neurophysiological effects of BDNF were abolished when co-incubated with PKC-selective antagonist GF109203X in BNST slices. a Scheme showing that CRHR1-selective antagonist R121919 together with BDNF was chronically and bilaterally infused through a cannula into ovBNST of CVMS mice for 7 days. Then maladaptive behaviors were compared (including EPM test, OF test, SPT test, and NSF test). b Open arm duration time of the EPM from MS+Saline mice (n = 10) compared to R121919 + BDNF-treated MS mice (n = 7). c Frequency that mice entered into the open arm of the EPM after infusion of R121919 + BDNF into ovBNST of CVMS mice (n = 7) compared to saline-infusions in MS mice (n = 10). d Distance traveled in the center of the open-field (OF) after infusion of R121919+BDNF into ovBNST of MS mice (n = 7) compared to saline-infused MS mice (n = 10). e Duration of time spent in the center of OF test after infusion of R121919+BDNF into ovBNST of MS mice (n = 7) compared to saline-infusion in CVMS mice (n = 10). f Frequency of entries in the OF center after infusion of R121919+forskolin into ovBNST in MS mice (n = 7) compared to saline-infusion in MS mice (n = 10). g Latency to pellet consumption in the NSF test after infusion of R121919 + BDNF into ovBNST of CVMS mice (n = 7) compared to saline-infusion in MS mice (n = 10). h Sucrose preference percentage after infusion of R121919 + BDNF into ovBNST in MS mice (n = 7) compared to saline-infusion in MS mice (n = 10). i Effect of pre-incubation of BNST slices from MS mice with 60 min R121919 + BDNF (n = 7 cells) on the M-current outward amplitude in ovBNST compared to vehicle-treated neurons from MS mice (n = 8 cells). j Pre-incubation of BNST slices from MS mice with 60 min R121919 + BDNF (n = 7 cells) compared to vehicle-treated neurons from MS mice (n = 8 cells). k Pre-incubation of BNST slices from MS mice with 60 min R121919 + BDNF (n = 7 cells) compared to vehicle-treated neurons from MS mice (n = 8 cells). l I–V plots of M-current after 100 μg/ml BDNF application (n = 8 cells) showed a decreased M-current (from −50 to −25 mV) compared with Controls (n = 8 cells). m Average mEPSC amplitude after 100 μg/ml BDNF application (n = 8 cells) was increased compared with Control cells (n = 8 cells). n Average mEPSC frequency after 100 μg/ml BDNF application (n = 8 cells) did not change compared to Control cells (n = 8 cells). *p < 0.05; **p < 0.01; ***p < 0.001; NS: nonsignificant different (p > 0.05). o PKC-selective antagonist GF109203X abolished the M-current suppression effect of BDNF when co-incubated with BDNF together with R121919 in BNST slices from MS-exposed mice. p GF109203X reversed the amplified mEPSC amplitude when co-incubated with BDNF together with R121919 in BNST slices from MS-exposed mice. q GF109203X had no effect on the mEPSC frequency when co-incubated with BDNF in BNST slices from MS-exposed mice. r BDNF has no effect on the M-current when co-incubated with GF109203X in BNST slices from Control mice. s BDNF has no effect on the mEPSC amplitude when co-incubated with GF109203X in BNST slices from Control mice. t BDNF has no effect on the mEPSC frequency when co-incubated with GF109203X in BNST slices from Control mice. u Our cellular model proposes that early-life stress (ELS) induces CRH production and BDNF release in BNST, then (1): CRH sequentially activates CRHR1, a Gs-protein coupled membrane receptor, which is linked to AC activation on the cell membrane (adenylyl cyclase; coupled to CRHR1). Activation of Gαs then triggers cAMP production, which in turn activates the PKA enzyme. Activation of PKA is thought to initiate two parallel phosphorylation pathways: phosphorylation of the KCNQ channel on the cellular membrane to mediate inhibition of the M-current; and phosphorylation of GluR1 subunit of AMPAR on the postsynaptic membrane increases its surface expression to mediate potentiation of mEPSC amplitude. The neuropeptides PACAP (which functions as an upstream stress regulator) and STEP (functions as a CRH inhibitor) function to activate and inhibit CRH, respectively, in the CRH-associated stress signaling network. Meanwhile, (2) BDNF production lies downstream of CRHR1. BDNF can activate the TrkB receptor on the cell membrane, which in turn activates phospholipase C (PLCϒ) to catalyze hydrolysis of membrane-bound PIP2 into IP3 and DAG; DAG then activates PKC to activate its downstream phosphorylation of KCNQ channel subunit and phosphorylation of GluR1 subunit on the postsynaptic membrane, which together mediate M-current inhibition and potentiated mEPSC amplitude. These two CRHR1-PKA and BDNF-PKC-mediated, parallel pathways can function independently and subsequently mediate suppression of the M-current and amplification of mEPSC amplitude, respectively.
Fig. 5 MS effects on maladaptive behaviors and BNST neurophysiological parameters persist in the presence of BDNF even when CRHR1 is blocked. Maladaptive neurophysiological effects of BDNF were abolished when co-incubated with PKC-selective antagonist GF109203X in BNST slices. a Scheme showing that CRHR1-selective antagonist R121919 together with BDNF was chronically and bilaterally infused through a cannula into ovBNST of CVMS mice for 7 days. Then maladaptive behaviors were compared (including EPM test, OF test, SPT test, and NSF test). b Open arm duration time of the EPM from MS+Saline mice (n = 10) compared to R121919 + BDNF-treated MS mice (n = 7). c Frequency that mice entered into the open arm of the EPM after infusion of R121919 + BDNF into ovBNST of CVMS mice (n = 7) compared to saline-infusions in MS mice (n = 10). d Distance traveled in the center of the open-field (OF) after infusion of R121919+BDNF into ovBNST of MS mice (n = 7) compared to saline-infused MS mice (n = 10). e Duration of time spent in the center of OF test after infusion of R121919+BDNF into ovBNST of MS mice (n = 7) compared to saline-infusion in CVMS mice (n = 10). f Frequency of entries in the OF center after infusion of R121919+forskolin into ovBNST in MS mice (n = 7) compared to saline-infusion in MS mice (n = 10). g Latency to pellet consumption in the NSF test after infusion of R121919 + BDNF into ovBNST of CVMS mice (n = 7) compared to saline-infusion in MS mice (n = 10). h Sucrose preference percentage after infusion of R121919 + BDNF into ovBNST in MS mice (n = 7) compared to saline-infusion in MS mice (n = 10). i Effect of pre-incubation of BNST slices from MS mice with 60 min R121919 + BDNF (n = 7 cells) on the M-current outward amplitude in ovBNST compared to vehicle-treated neurons from MS mice (n = 8 cells). j Pre-incubation of BNST slices from MS mice with 60 min R121919 + BDNF (n = 7 cells) compared to vehicle-treated neurons from MS mice (n = 8 cells). k Pre-incubation of BNST slices from MS mice with 60 min R121919 + BDNF (n = 7 cells) compared to vehicle-treated neurons from MS mice (n = 8 cells). l I–V plots of M-current after 100 μg/ml BDNF application (n = 8 cells) showed a decreased M-current (from −50 to −25 mV) compared with Controls (n = 8 cells). m Average mEPSC amplitude after 100 μg/ml BDNF application (n = 8 cells) was increased compared with Control cells (n = 8 cells). n Average mEPSC frequency after 100 μg/ml BDNF application (n = 8 cells) did not change compared to Control cells (n = 8 cells). *p < 0.05; **p < 0.01; ***p < 0.001; NS: nonsignificant different (p > 0.05). o PKC-selective antagonist GF109203X abolished the M-current suppression effect of BDNF when co-incubated with BDNF together with R121919 in BNST slices from MS-exposed mice. p GF109203X reversed the amplified mEPSC amplitude when co-incubated with BDNF together with R121919 in BNST slices from MS-exposed mice. q GF109203X had no effect on the mEPSC frequency when co-incubated with BDNF in BNST slices from MS-exposed mice. r BDNF has no effect on the M-current when co-incubated with GF109203X in BNST slices from Control mice. s BDNF has no effect on the mEPSC amplitude when co-incubated with GF109203X in BNST slices from Control mice. t BDNF has no effect on the mEPSC frequency when co-incubated with GF109203X in BNST slices from Control mice. u Our cellular model proposes that early-life stress (ELS) induces CRH production and BDNF release in BNST, then (1): CRH sequentially activates CRHR1, a Gs-protein coupled membrane receptor, which is linked to AC activation on the cell membrane (adenylyl cyclase; coupled to CRHR1). Activation of Gαs then triggers cAMP production, which in turn activates the PKA enzyme. Activation of PKA is thought to initiate two parallel phosphorylation pathways: phosphorylation of the KCNQ channel on the cellular membrane to mediate inhibition of the M-current; and phosphorylation of GluR1 subunit of AMPAR on the postsynaptic membrane increases its surface expression to mediate potentiation of mEPSC amplitude. The neuropeptides PACAP (which functions as an upstream stress regulator) and STEP (functions as a CRH inhibitor) function to activate and inhibit CRH, respectively, in the CRH-associated stress signaling network. Meanwhile, (2) BDNF production lies downstream of CRHR1. BDNF can activate the TrkB receptor on the cell membrane, which in turn activates phospholipase C (PLCϒ) to catalyze hydrolysis of membrane-bound PIP2 into IP3 and DAG; DAG then activates PKC to activate its downstream phosphorylation of KCNQ channel subunit and phosphorylation of GluR1 subunit on the postsynaptic membrane, which together mediate M-current inhibition and potentiated mEPSC amplitude. These two CRHR1-PKA and BDNF-PKC-mediated, parallel pathways can function independently and subsequently mediate suppression of the M-current and amplification of mEPSC amplitude, respectively.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 103 references

Cited by

  • The HPA Axis as Target for Depression

    Menke, A. (2024) · Current Neuropharmacology · doi:10.2174/1570159x21666230811141557 · Cited by 131

    “Early-life stress, such as physical, sexual, or emotional childhood trauma, has been generally associated with MDD [23, 24], but the increase of MDD risk is also moderated by genetic variants, for example, by FKBP5 variants [25], encoding the FK 506 binding protein 51 or FKBP51, a co-chaperone of…”
    Background

See all 49

Metadata

Authors
Hu, P., Maita, I., Phan, M. L., Gu, E., Kwok, C., Dieterich, A., Gergues, M. M., Yohn, C. N., Wang, Y., Zhou, J.-N., Qi, X.-R., Swaab, D. F., Pang, Z. P., Lucassen, P. J., Roepke, T. A., & Samuels, B. A.
Affiliations
  • Rutgers, The State University of New Jersey (US)
  • University of Science and Technology of China (CN)
  • Tongji University (CN)
  • Netherlands Institute for Neuroscience (NL)
  • University of Amsterdam (NL)
Corresponding author
  • Roepke, Troy A.
  • Samuels, Benjamin A.
Venue
Translational Psychiatry
Published
2020-11-11
Volume
10
Issue
1
Pages
396-396
ISSN
2158-3188 (ISSN-L)
OpenAlex
W3100193186
Cited by
49
References
103
Citations by year
2026: 4 · 2025: 14 · 2024: 11 · 2023: 7 · 2022: 5 · 2021: 7
FWCI
2.66
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • UvA-DARE (University of Amsterdam) (submittedVersion, cc-by)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion, other-oa)
Funders
Robert Wood Johnson Foundation Grant #74260
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
Keywords
early life stress, maternal separation, corticotropin-releasing factor, bed nucleus of the stria terminalis, brain-derived neurotrophic factor, CRHR1, PACAP, STEP, M-current, neuronal excitability, miniature excitatory postsynaptic currents, protein kinase C, anxiety, depression, stress-related psychopathology, neuroplasticity
MeSH terms
Animals, Corticotropin-Releasing Hormone, Male, Maternal Deprivation, Septal Nuclei, Stress, Psychological, Brain-Derived Neurotrophic Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early-life stress alters affective behaviors in adult mice through persistent activation of CRH-BDNF signaling in the oval bed nucleus of the stria terminalis. https://app.cochat.ai/papers/10.1038/s41398-020-01070-3
The paper
Hu, P., Maita, I., Phan, M. L., Gu, E., Kwok, C., Dieterich, A., Gergues, M. M., Yohn, C. N., Wang, Y., Zhou, J.-N., Qi, X.-R., Swaab, D. F., Pang, Z. P., Lucassen, P. J., Roepke, T. A., & Samuels, B. A. (2020). Early-life stress alters affective behaviors in adult mice through persistent activation of CRH-BDNF signaling in the oval bed nucleus of the stria terminalis. Translational Psychiatry. https://doi.org/10.1038/s41398-020-01070-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.